'No One Violates Privacy Like Meta': Scott Galloway Says Years of User Data Could Become an AI Advantage
Scott Galloway says Meta’s years of user data could give Muse an AI edge even if its models lag Anthropic and OpenAI.
Economy · News reference
Despite record fuel prices, U.S. growth remains strong, driven by resilient consumer spending and a surge in AI-related corporate investment.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Scott Galloway says Meta’s years of user data could give Muse an AI edge even if its models lag Anthropic and OpenAI.
SpaceX sidestepped Brownsville restrictions as SemiAnalysis says 300+ data-center rules have delayed just three U.S. projects.
Nvidia CEO Jensen Huang announced the company could double chip sales next year, driven by the new Vera Rubin architecture that offers 30x more performance and 97% lower inference costs than Blackwell Ultra. While the stock trades at a low P/E ratio of 28.1, risks include potential AI development slowdowns, rising interest rates affecting hyperscaler spending, and Nvidia financing 25% of fiscal 2028 sales to customers.
The global fitness tracker market is projected to grow from USD 71.2 billion in 2026 to USD 91.6 billion by 2033, with a CAGR of 3.70%. Growth is driven by AI-enabled wearables, rising health awareness, integration with healthcare platforms, and expanding adoption in emerging markets. Key opportunities exist in affordable devices, multifunctional wearables, and partnerships with healthcare and wellness providers.
Glass, a Silicon Valley GovTech company, launched an AI-powered G-Commerce Supplier Experience platform that enables businesses to sell products and services to government agencies through a centralized marketplace. The platform features AI-powered verification, a supplier API for catalog integration, order management tools, and support resources to help suppliers navigate government procurement.
An official report on September 18, 2026 reveals Representative Pete Sessions's recent sale of AbbVie (NYSE:ABBV) stock, valued between $30,002 and $100,000. The transaction took place on September 14, 2026, as per